Seven myths of randomisation in clinical trials

Statistics in Medicine

Volumn 32, Issue 9, 2013, Pages 1439-1450

  Senn, Stephen ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Blinding; Conditioning; Covariates; Randomisation

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; STEROID;

ANALYSIS OF COVARIANCE; ARTICLE; ASTHMA; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONDITIONING; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; PROGNOSIS; RANDOMIZATION; STUDY DESIGN;

EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876307276     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5713     Document Type: Article

References (54)

1. Howson C, Urbach P. Scientific Reasoning: The Bayesian Approach. Open Court: La Salle, 1989.
2. Urbach P. Randomization and the design of experiments. Philosophy of Science 1985; 52:256-273.
3. Worrall J. What evidence is evidence based medicine. Philosophy of Science 2002; 69:S316-S330.
4. Worrall J. Why there's no cause to randomize. British Journal for the Philosophy of Science 2007; 58:451-488.
5. Borgerson K. Valuing evidence: bias and the evidence hierarchy of evidence-based medicine. Perspectives in Biology and Medicine 2009; 52:218-233.
6. Senn SJ. Added values: controversies concerning randomization and additivity in clinical trials. Statistics in Medicine 2004; 23:3729-3753.
7. Senn SJ. Baseline balance and valid statistical analyses: common misunderstandings. Applied Clinical Trials 2005; 14:24-27.
8. Senn SJ. Covariate imbalance and random allocation in clinical trials [see comments]. Statistics in Medicine 1989; 8:467-475.
9. Senn SJ. Testing for baseline balance in clinical trials. Statistics in Medicine 1994; 13:1715-1726.
10. Fisher RA. The design of experiments. In The Design of Experiments, Bennett H (ed.). Oxford: Oxford City; 1990.
11. Senn SJ. Fisher's game with the devil. Statistics in Medicine 1994; 13:217-230.
12. Senn SJ. Dicing with Death. Cambridge University Press: Cambridge, 2003.
13. Lindley DV. A Bayesian lady tasting tea. In Statistics: An Appraisal, David HA, David HT (eds). Iowa State Press: Ames, 1984; 455-485.
14. Bennett JH. Statistical Inference and Analysis Selected Correspondence of R.A. Fisher. Oxford University Press: Oxford, 1990.
15. Blackmore S. The lure of the paranormal. New Scientist 1990; 22:62-65.
16. Lesaffre E, Senn S. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials. Statistics in Medicine 2003; 22:3583-3596.
17. Senn SJ, Anisimov VV, Fedorov VV. Comparisons of minimization and Atkinson's algorithm. Statistics in Medicine 2010; 29:721-730.
18. Senn SJ. Statistical Issues in Drug Development. Wiley: Hoboken, 2007.
19. Atkinson AC. Optimum biased-coin designs for sequential treatment allocation with covariate information. Statistics in Medicine 1999; 18:1741-1752.
20. Burman C-F. On Sequential Treatment Allocations in Clinical Trials. Chalmers University of Technology: Gothenburg, 1996.
21. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. British Journal of Cancer 1976; 34:585-612.
22. Senn S. Modelling in drug development. In Simplicity, Complexity and Modelling, Christie M, Cliffe A, Dawid AP, Senn S (eds). Wiley: Chichester, 2011; 35-49.
23. Senn S, Anisimov VV, Fedorov VV. Comparisons of minimization and Atkinson's algorithm. Statistics in Medicine 2010; 29:721-730.
24. Senn SJ. Some controversies in planning and analysing multi-centre trials. Statistics in Medicine 1998; 17:1753-1765; discussion 1799-1800.
25. Cox DR. Planning of Experiments. John Wiley: New York, 1958.
26. Rosenberger WF, Lachin JM. Randomization in Clinical Trials: Theory and Practice. Wiley: New York, 2002.
27. Nelder JA. The analysis of randomised experiments with orthogonal block structure I. Block structure and the null analysis of variance. Proceedings of the Royal Society of London. Series A 1965; 283:147-162.
28. Nelder JA. The analysis of randomised experiments with orthogonal block structure II. Treatment structure and the general analysis of variance. Proceedings of the Royal Society of London. Series A 1965; 283:163-178.
29. Senn SJ, Nelder J. From general balance to generalised models (both linear and hierarchical). In Methods and Models in Statistics: In Honour of Professor John Nelder, FRS, Adams NM, Crowder MJ, Hand DJ, Stephens DA (eds). Imperial College Press: London, 2004; 1-11.
30. Bailey RA. Principles of designed experiments in J. A. Nelder's papers. In Methods and Models in Statistics: In Honour of Professor John Nelder, FRS, Adams N, Crowder M, Hand D, Stephens D (eds). Imperial College Press: London, 2004; 171-194.
31. Senn SJ. Cross-over Trials in Clinical Research, 2nded. Wiley: Chichester, 2002.
32. Hills M, Armitage P. The two-period cross-over clinical trial. British Journal of Clinical Pharmacology 1979; 8:7-20.
33. Fisher RA. The Design of Experiments. Oliver and Boyd: Edinburgh, 1935.
34. Pitman EJG. Significance tests which may be applied to samples from any population. Journal of the Royal Statistical Society, Supplement 1937; 4:119-130.
35. Colquhoun D. Lectures on Biostatistics. Clarendon Press: Oxford, 1971.
36. Grieve AP. A Bayesian analysis of the two-period crossover design for clinical trials. Biometrics 1985; 41:979-990.
37. Teather D, Morrey GH. Bayesian methods in cross-over trials. Byocybernetics and Biomedical Engineering 1995; 15:41-52.
38. Fisher RA. Statistical methods for research workers. In Statistical Methods, Experimental Design and Scientific Inference, Bennet JH (ed.). Oxford University: Oxford, 1925.
39. Cumberland WG, Royall RM. Does simple random sampling provide adequate balance? Journal of the Royal Statistical Society Series B- Methodological 1988; 50:118-124.
40. Royall RM, Cumberland WG. Conditional coverage properties of finite population confidence-intervals. Journal of the American Statistical Association 1985; 80:355-359.
41. Cox DR, McCullagh P. Some aspects of analysis of covariance. Biometrics 1982; 38:541-554.
42. Popper SJ. The Gauss-Markov theorem and random regressors. The American Statistician 1991; 45:269-272.
43. Senn SJ, Graf E, Caputo A. Stratification for the propensity score compared with linear regression techniques to assess the effect of treatment or exposure. Statistics in Medicine 2007; 26:5529-5544.
44. Fang BQ, Dawid AP. Nonconjugate Bayesian regression on many variables. Journal of Statistical Planning and Inference 2002; 103:245-261.
45. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clinical Pharmacology and Therapeutics 1974; 15:443-453.
46. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103-115.
47. McEntegart D. The pursuit of balance using stratified and dynamic randomization techniques: an overview. Drug Information Journal 2003; 37:293-308.
48. Buyse M, McEntegart D. Achieving balance in clinical trials. Applied Clinical Trials 2004; 13:36-40.
49. Taves DR. Rank-minimization with a two-step analysis should replace randomization in clinical trials. Journal of Clinical Epidemiology 2012; 65:3-6.
50. Rosenberger WF, Sverdlov O, Hu F. Adaptive randomization for clinical trials. Journal of Biopharmaceutical Statistics 2012; 22:719-736.
51. Day S, Groulin J-M, Lewis JA. Achieving balance in clinical trials. Applied Clinical Trials 2005; 14:24-26.
52. Atkinson AC. The comparison of designs for sequential clinical trials with covariate information. Journal of the Royal Statistical Society Series A-Statistics in Society 2002; 165:349-373.
53. Senn SJ. Statistical Issues in Drug Development, 2nded. Wiley: Hoboken, 2007.
54. Bailey RA. A unified approach to design of experiments. Journal of the Royal Statistical Society Series A-Statistics in Society 1981; 144:214-223.